Rogan says Trump called ibogaine approval 'sounds good to me'

Podcast host Joe Rogan is pushing back against criticism of his recent White House visit, reiterating his political independence while revealing new details about a conversation with President Donald Trump regarding ibogaine, a controversial substance being studied for addiction treatment.

Rogan, whose show reaches millions of listeners, faced significant backlash on social media after his visit to the White House became public. Critics accused him of aligning himself with the Trump administration, a charge he firmly denied. Rogan emphasized that he has never endorsed a presidential candidate and considers himself independent, pointing to his history of interviewing figures from across the political spectrum.

The conversation about ibogaine appears to have been a central topic during Rogan's interaction with the president. Ibogaine, a psychoactive compound derived from an African plant, has gained attention in recent years for its potential to treat opioid and other addictions, though it remains unsanctioned for medical use in the United States. Advocates have been pushing for federal research and potential approval pathways.

According to Rogan, the president's response to the idea of advancing ibogaine approval was positive, with Trump indicating it "sounds good to me." Whether that informal expression of interest translates into any policy movement remains uncertain, as the regulatory process for such substances is lengthy and involves multiple federal agencies.

The intersection of celebrity advocacy and drug policy is not new, but Rogan's massive platform gives the ibogaine conversation unusual reach. Addiction treatment advocates have welcomed the attention, while critics caution that policy decisions on experimental treatments should be driven by science, not celebrity influence.

The episode also highlights the ongoing debate over the role of media personalities in shaping public policy, particularly when those figures have access to the highest levels of government.

What This Means For You: If you or someone you know is struggling with addiction, ibogaine is getting unprecedented mainstream attention — but it's still not approved for treatment in the U.S. The conversation is moving, though, and a president expressing openness could accelerate research funding. Watch for any movement on federal clinical trials, but don't bank on quick changes to treatment options.